BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kong L, Wei G, Lv T, Jiang L, Yang J, Zhao Y, Yang J. Outcome of TACE treatment in HIV infected patients with hepatocellular carcinoma. Sci Rep 2021;11:696. [PMID: 33436856 DOI: 10.1038/s41598-020-80311-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Nartey YA, Zhou K, Kim M, Falade-nwulia O, Tucker JD. HIV: hepatic manifestations of HIV and antiretroviral therapy. Comprehensive Guide to Hepatitis Advances 2023. [DOI: 10.1016/b978-0-323-98368-6.00006-9] [Reference Citation Analysis]
2 Tang X, He X, Jiang H. Efficacy and safety of HIFU in combination with TACE in unresectable pediatric HB: A randomized, controlled, single-center clinical trial. Medicine (Baltimore) 2022;101:e32022. [PMID: 36482636 DOI: 10.1097/MD.0000000000032022] [Reference Citation Analysis]
3 Yang Y, Chen S, Yan Z, Jiao Y, Yan X, Li Y, Zheng P. Construction and Validation of Prediction Model of Severe Abdominal Pain Post-Transarterial Chemoembolization in Patients with HBV-Associated Primary Liver Cancer. Computational and Mathematical Methods in Medicine 2022;2022:1-6. [DOI: 10.1155/2022/5203166] [Reference Citation Analysis]
4 Zhao Y, Kong LX, Feng FS, Yang J, Wei G. A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort study. BMC Cancer 2022;22:311. [PMID: 35321670 DOI: 10.1186/s12885-022-09433-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Micali C, Russotto Y, Caci G, Ceccarelli M, Marino A, Celesia BM, Pellicanò GF, Nunnari G, Venanzi Rullo E. Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV. Infectious Disease Reports 2022;14:43-55. [DOI: 10.3390/idr14010006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
6 Pan Y, Chang R, He Z, Hong M. How to prophylactically alleviate postembolization syndrome following transarterial chemoembolization?: Protocol of a double blinded, randomized, placebo-controlled trial. Medicine (Baltimore) 2021;100:e25360. [PMID: 33832116 DOI: 10.1097/MD.0000000000025360] [Reference Citation Analysis]